GlassScriptPhysician profile
Jennifer A Henrich
NPI 1174045090
$2,046.61
in general payments reported to CMS, 2019-2025
25 companies · $251 in 2025
The $251 reported for 2025 was more than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $146 · 2020: $39.51 · 2021: $63.52 · 2022: $521 · 2023: $705 · 2024: $321 · 2025: $251.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,191 · Education: $85.95.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,191.34 |
| Education | $85.95 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $284.02 | 2019-2024 | Veozah, Myrbetriq |
| Exeltis, USA INC. | $260.36 | 2022-2025 | Slynd, Solosec |
| Abbvie INC. | $254.77 | 2019-2022 | |
| Gynesonics, INC. | $204.61 | 2022-2024 | Sonata Sonography-Guided Transcervical Fibroid Ablation System |
| Mayne Pharma Commercial LLC | $175.10 | 2021-2025 | |
| Hologic Sales and Service, LLC | $121.10 | 2022-2025 | Acessa Provu System, Myosure Tissue Removal Device, Novasure |
| Channel Medsystems, INC. | $103.10 | 2023 | |
| Organon LLC | $90.71 | 2022-2025 | Nexplanon |
| Aspira Women'S Health INC | $85.86 | 2023 | Ova1 |
| Pfizer INC. | $51.83 | 2023-2025 | |
| Therapeuticsmd, INC. | $46.22 | 2022 | |
| Coopersurgical, INC. | $44.07 | 2022-2023 | Paragard T 380a |
| Sage Therapeutics, LLC | $42.89 | 2025 | Zurzuvae |
| Sumitomo Pharma America, INC. | $41.93 | 2023-2025 | Myfembree |
| Intuitive Surgical, INC. | $39.01 | 2021-2024 |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bayer Healthcare Pharmaceuticals INC. | $27.94 | 2021-2023 | |
| Celgene Corporation | $22.89 | 2019 | |
| Scynexis, INC. | $22.22 | 2022 | |
| Alexion Pharmaceuticals, INC. | $22.07 | 2019 | |
| Agile Therapeutics, INC. | $21.55 | 2022 | |
| Daiichi Sankyo INC. | $18.67 | 2022 | |
| Amgen INC. | $17.81 | 2023 | Evenity, Prolia |
| Boston Scientific Corporation | $17.36 | 2019 | |
| Millicent US INC | $15.88 | 2025 | Femlyv |
| Merck Sharp & Dohme LLC | $14.64 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jennifer Henrich listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.